TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

0 avis

TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma

Archive ouverte

Edité par CCSD ; American Association for Cancer Research -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade

Archive ouverte | Biton, Jérôme | CCSD

International audience

Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors

Archive ouverte | Mansuet-Lupo, Audrey | CCSD

International audience

Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy

Archive ouverte | Paolini, Léa | CCSD

International audience. Background A high density of resident memory T cells (TRM) in tumors correlates with improved clinical outcomes in immunotherapy-treated patients. In most clinical studies, TRM are defined by...

Chargement des enrichissements...